GSH/pH Dual-Responsive Zwitterionic mRNA Nanocomplexes for Tumor-Enriched mRNA Delivery in a B16F10 Melanoma Model
Messenger RNA (mRNA) therapy offers a programmable route to melanoma treatment, but its translation is limited by nuclease degradation, off-target biodistribution and endolysosomal trapping. Here we report a glutathione (GSH)/pH dual-responsive mRNA nanocomplex (mRNA-NC) fabricated by one-pot in situ polymerization of N-(3-aminopropyl)methacrylamide (APMA), 1-vinylimidazole (VI), N,N'-bis(acryloyl)cystamine (BACA), and 2-methacryloyloxyethyl phosphorylcholine (MPC) on the mRNA template. At an N/P ratio of 40, the carrier reached an encapsulation efficiency of 92.7 ± 2.1% and a loading capacity of 87.4 ± 3.2 μg mg-1, forming monodisperse particles of 126.4 ± 7.2 nm (polydispersity index, PDI, 0.14). The zwitterionic corona limited plasma protein adsorption to 12.6 ± 1.5 μg mg-1 (4.6-fold lower than jetPEI/mRNA), kept hemolysis at 0.8 ± 0.2%, and extended the serum half-life of the mRNA to ≈27.4 h, roughly 9-fold longer than naked mRNA. Release was gated by both triggers: 86.5 ± 3.7% of the cargo was released within 8 h under 10 mM GSH, whereas leakage under physiological conditions remained ≤ 12%; in a 4 h matrix, pH 5.5 plus 10 mM GSH released 85 ± 6.8% versus 12 ± 1.5% at pH 7.4 without GSH. In B16F10 cells, the nanocomplex was taken up in a dose- and energy-dependent manner, entered the lysosomal compartment, and escaped over time in a manner consistent with imidazole-mediated proton-sponge buffering (a hypothesis; intralysosomal pH was not measured directly), producing a peak firefly luciferase (FLuc) expression of 56,140 ± 3280 RLU mg-1 protein at 24 h, about 1.5-fold higher than jetPEI/mRNA, with 93.6 ± 3.9% cell viability and 6.7 ± 1.2% lactate dehydrogenase (LDH) release. In B16F10-bearing albino C57BL/6 mice, a single intravenous dose produced tumor-dominant bioluminescence (peak 5.7 × 106 photons s-1 at 6 h), a tumor enrichment index of 1.22 ± 0.18 (vs 0.31 ± 0.03 for jetPEI/mRNA) and 2.42 × 107 FLuc mRNA copies μg-1 tumor RNA at 12 h, while all 7-day safety indicators remained at phosphate-buffered saline (PBS) levels. These results demonstrate that a single zwitterionic nanocomplex can integrate stealth, dual-triggered release, and endosomal escape for safe, tumor-enriched mRNA delivery. While this study focuses on delivery performance and reporter gene expression, it lays a solid foundation for future therapeutic applications with functional mRNA.
Authors
- Jia Yu (ORCID: https://orcid.org/0000-0001-8342-5423)
- Xueying Zhou (ORCID: https://orcid.org/0009-0006-7398-3863)
- Tangna Hao
- Sha Wu (ORCID: https://orcid.org/0000-0002-4185-3275)
- Lijun Chang
- Ying Wang
Institutions
- Dalian Medical University (CN)
- Second Affiliated Hospital of Dalian Medical University (CN)
Publication Details
- Journal
- ACS Applied Materials & Interfaces
- Published
- 2026-11-13
- DOI
- https://doi.org/10.1021/acsami.6c22110
- Primary Topic
- RNA Interference and Gene Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Liaoning Province